Jail-based hepatitis c cure program aims to eliminate virus behind bars
NCT ID NCT06953479
First seen Mar 01, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tests whether a low-barrier hepatitis C treatment program can help people in jail start and finish treatment more easily. Forty adults awaiting trial at the Rhode Island Department of Corrections will receive a 12-week course of the HCV medication Epclusa, and if released early, they will take remaining doses with them. Community health workers will support participants after release. The goal is to cure HCV and see if this approach could be used in other jails.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C (HCV) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rhode Island Department of Corrections
RECRUITINGCranston, Rhode Island, 02920, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.